TABLE 2.
— | N | 95% CI | |||
---|---|---|---|---|---|
Lower | Upper | p-value | |||
Sex | Female | 32 | 44.344 | 59.210 | 0.048 |
Male | 82 | 37.524 | 47.943 | ||
Age group | <65 years | 85 | 41.353 | 51.432 | 0.357 |
≥65 years | 29 | 33.415 | 50.281 | ||
Tumor stage | T1 or T2 | 46 | 50.219 | 60.281 | 0.001 |
T3 or T4 | 68 | 32.621 | 44.444 | ||
Lymph node metastasis | N0 | 51 | 47.522 | 58.686 | 0.002 |
Nx | 63 | 33.024 | 44.976 | ||
Grades of differentiation | G1 or G2 | 93 | 39.684 | 49.429 | 0.979 |
G3 | 9 | 26.669 | 56.183 | ||
UICC stage | I or II | 64 | 47.030 | 56.931 | 0.001 |
III or IV | 50 | 29.825 | 43.627 | ||
PD-1H expression | Low | 85 | 37.550 | 47.429 | 0.029 |
High | 29 | 45.389 | 60.823 |
CI, confidence interval; HR, hazard ratio; UICC, union for international cancer control; PD-1H, programmed death-1 homolog; ESCC, esophageal squamous cell carcinoma.